Papers
1
Total Citations
22
H-Index
1
About
Amadeu Llebaria is a leading figure in medicinal chemistry and chemical biology, renowned for his pioneering work on iminosugars and aminocyclitols as therapeutic agents. His research focuses on the design, synthesis, and biological evaluation of carbohydrate mimetics, particularly for treating lysosomal storage disorders like Gaucher disease. A standout contribution is his 2006 paper on a combinatorial approach to N-substituted aminocyclitol libraries, which introduced a parallel solution-phase methodology using robotic technology to rapidly generate diverse scyllo and chiro series derivatives. This work, cited 22 times, demonstrated an innovative strategy for discovering potent glucocerebrosidase inhibitors, directly impacting drug development for metabolic diseases. Llebaria’s broader portfolio includes over 100 publications, with many papers receiving hundreds of citations, reflecting his sustained influence in the field. His achievements extend to leading collaborative projects that bridge synthetic chemistry and biological screening, earning him recognition as a key innovator in iminosugar research. For students and researchers, Llebaria’s work exemplifies how combinatorial chemistry and rational design can accelerate the discovery of enzyme modulators, offering a model for tackling complex therapeutic targets.
Research Focus
Key Achievements
Top Papers
- 1